| Diagnostic point-of-care tests in resource-limited settings PK Drain, EP Hyle, F Noubary, KA Freedberg, D Wilson, WR Bishai, ... The Lancet infectious diseases 14 (3), 239-249, 2014 | 759 | 2014 |
| Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study MP Warren, J Brooks-Gunn, RP Fox, CC Holderness, EP Hyle, ... The Journal of Clinical Endocrinology & Metabolism 87 (7), 3162-3168, 2002 | 293 | 2002 |
| Functional hypothalamic amenorrhea: hypoleptinemia and disordered eating MP Warren, F Voussoughian, EB Geer, EP Hyle, CL Adberg, RH Ramos The Journal of Clinical Endocrinology & Metabolism 84 (3), 873-877, 1999 | 270 | 1999 |
| Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase–producing Enterobacteriaceae: variability by site of infection EP Hyle, AD Lipworth, TE Zaoutis, I Nachamkin, WB Bilker, E Lautenbach Archives of internal medicine 165 (12), 1375-1380, 2005 | 246 | 2005 |
| Cardiovascular disease projections in the United States based on the 2020 census estimates R Mohebi, C Chen, NE Ibrahim, CP McCarthy, HK Gaggin, DE Singer, ... Journal of the American College of Cardiology 80 (6), 565-578, 2022 | 191 | 2022 |
| Persistent osteopenia in ballet dancers with amenorrhea and delayed menarche despite hormone therapy: a longitudinal study MP Warren, J Brooks-Gunn, RP Fox, CC Holderness, EP Hyle, ... Fertility and sterility 80 (2), 398-404, 2003 | 182 | 2003 |
| Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species EP Hyle, AD Lipworth, TE Zaoutis, I Nachamkin, NO Fishman, WB Bilker, ... Clinical infectious diseases 40 (9), 1317-1324, 2005 | 165 | 2005 |
| Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States KP Reddy, CY Kong, EP Hyle, TP Baggett, M Huang, RA Parker, ... JAMA internal medicine 177 (11), 1613-1621, 2017 | 130 | 2017 |
| Global action plan on HIV drug resistance 2017–2021 World Health Organization World Health Organization, 2017 | 119 | 2017 |
| Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study KP Reddy, FM Shebl, JHA Foote, G Harling, JA Scott, C Panella, ... The Lancet Global Health 9 (2), e120-e129, 2021 | 100 | 2021 |
| HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? EP Hyle, K Naidoo, AE Su, WM El-Sadr, KA Freedberg JAIDS Journal of Acquired Immune Deficiency Syndromes 67, S87-S95, 2014 | 100 | 2014 |
| Waiting for certainty on Covid-19 antibody tests—at what cost? MC Weinstein, KA Freedberg, EP Hyle, AD Paltiel New England Journal of Medicine 383 (6), e37, 2020 | 92 | 2020 |
| Pocket medicine MS Sabatine Lippincott Williams & Wilkins, 2013 | 91 | 2013 |
| College campuses and COVID-19 mitigation: clinical and economic value E Losina, V Leifer, L Millham, C Panella, EP Hyle, AM Mohareb, ... Annals of internal medicine 174 (4), 472-483, 2021 | 90 | 2021 |
| Clinical impact, costs, and cost-effectiveness of expanded severe acute respiratory syndrome coronavirus 2 testing in Massachusetts AM Neilan, E Losina, AC Bangs, C Flanagan, C Panella, GE Eskibozkurt, ... Clinical Infectious Diseases 73 (9), e2908-e2917, 2021 | 88 | 2021 |
| Racial and ethnic disparities in disease severity on admission chest radiographs among patients admitted with confirmed coronavirus disease 2019: a retrospective cohort study NP Joseph, NJ Reid, A Som, MD Li, EP Hyle, CM Dugdale, M Lang, ... Radiology 297 (3), E303-E312, 2020 | 85 | 2020 |
| Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness IV Bassett, D Govindasamy, AS Erlwanger, EP Hyle, K Kranzer, ... PloS one 9 (1), e85197, 2014 | 81 | 2014 |
| The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review EP Hyle, BM Mayosi, K Middelkoop, M Mosepele, EB Martey, ... BMC public health 17, 1-15, 2017 | 75 | 2017 |
| The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis EP Hyle, IV Jani, J Lehe, AE Su, R Wood, J Quevedo, E Losina, IV Bassett, ... PLoS medicine 11 (9), e1001725, 2014 | 72 | 2014 |
| Projecting 10-year, 20-year, and lifetime risks of cardiovascular disease in persons living with human immunodeficiency virus in the United States E Losina, EP Hyle, ED Borre, BP Linas, PE Sax, MC Weinstein, C Rusu, ... Clinical Infectious Diseases 65 (8), 1266-1271, 2017 | 67 | 2017 |
